COMBINATION THERAPY WITH ANTI-CD19 ANTIBODY AND A PURINE ANALOG Russian patent published in 2018 - IPC C07K16/28 A61K39/395 

Abstract RU 2664462 C9

FIELD: biochemistry.

SUBSTANCE: invention relates to biochemistry, in particular to the use of an antibody specific to CD19 and fludarabine to produce a synergistic combination for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and/or acute lymphoblastic leukemia.

EFFECT: invention effectively treats non-Hodgkin's lymphoma, chronic lymphocytic leukemia and/or acute lymphoblastic leukemia.

13 cl, 11 tbl, 3 ex

Similar patents RU2664462C9

Title Year Author Number
COMBINED THERAPY WITH CD19 ANTIBODY AND NITROGEN MUSTARD 2012
  • Amersdorfer Yutta
  • Shtajdl Shtefan
  • Vinderlikh Mark
  • Kron Suzanne
  • Rojker Liza
RU2625222C2
COMBINATION OF CD19 ANTIBODY WITH BCL-2 INHIBITOR AND ITS APPLICATION METHODS 2017
  • Endell Jan
  • Petropoulos Konstantin
  • Kelemen Peter
  • Boxhammer Rainer
  • Ruckert Markus
RU2756405C2
COMBINATIONS AND USE THEREOF 2016
  • Endell Jan
  • Winderlich Mark
  • Boxhammer Rainer
RU2767063C2
COMBINATION OF CD19 ANTIBODY AND BRUTON TYROSINE KINASE INHIBITOR AND THEIR APPLICATION 2016
  • Endell Jan
  • Boxhammer Rainer
  • Winderlich Mark
RU2756010C2
FORMULATIONS BASED ON CD19 ANTIBODY 2017
  • Garidel Patrick
  • Langer Andreas
  • Hessling Martin
  • Weinfurtner Daniel
  • Brocks Bodo
RU2748024C2
TREATMENT APPROACH DESIGNED TO TREAT WITH A COMBINATION OF ANTI-CD19 ANTIBODY AND VENETOCLAX 2018
  • Kelemen Peter
  • Schwarz Michael
  • Winderlich Mark
  • Heeger Steffen
  • Weinelt Dominika
RU2802812C2
OLIGONUCLEOTIDES OR THEIR FUNCTIONAL HOMOLOGUES, COMPOSITION CONTAINING THEM AND METHOD OF TREATING B-CELL TUMOUR 2006
  • Van Li-In
  • Bao Mu-Shehn
  • Juj Jun-Li
RU2413519C2
TREATMENT OF B-CELLULAR MALIGNANT TUMORS USING ANTI-CD40L ANTIBODIES IN COMBINATION WITH ANTI-CD20 ANTIBODIES AND/OR BY CHEMOTHERAPY AND RADIOTHERAPY 2000
  • Khanna Nabil
  • Kharikharan Kandasami
RU2305561C2
METHOD FOR TREATING THE CASES OF MALIGNANT TUMORS CONTAINING B-CELLS WITH A COMBINATION OF APPLICATIONS RELATED TO ANTIBODIES REDUCING B-CELLS NUMBER AND WITH IMMUNOMODULATING ANTIBODIES 2001
  • Khanna Nabil
  • Kharikharan Kandasami
RU2306952C2
DECREASING B-CELL COUNT WITH USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES 2006
  • Grosmehjr Laura S'Ju
  • Khajdehn-Ledbehttehr Marta S'Juzan
  • Ledbehttehr Dzheffri A.
  • Tompson Piter Armstrong
  • Sajmon Sandi Aleksander
  • Brehdi Uill'Jam
RU2423381C2

RU 2 664 462 C9

Authors

Amersdorffer Jutta

Steidl Stefan

Winderlich Mark

Krohn Susanne

Rojkjaer Lisa

Dates

2018-08-17Published

2012-08-14Filed